Alternative mix-and-match COVID-19 vaccine administration versus standard vaccination for prevention of severe COVID-19: A specific cost utility analysis

Till now,over 220 million people throughout the world have already been affected by coronavirus disease(COVID-19).Vaccination is the most effective strategy to prevent the spread of COVID-19[1].Several pharmaceutical companies have announced the success of their COVID-19 vaccine study.Additional publications on the vaccine's efficacy and inoculation costs are available.When it comes to a new immunization,the cost and accessibility of the vaccine are crucial considerations[2].